Geoffrey Mackay

Insider Reports History

Entity
Individual
Location
C/O Avrobio, Inc., One Kendall Sq, Bldg. 300, Ste. 201, Cambridge, MA
Signature
/s/ Mary Kay Fenton, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Geoffrey Mackay:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AVROBIO, Inc. President & CEO, Director Common Stock 445K $536K $1.21 Dec 28, 2022 By The Geoff R. MacKay Irrevocable Trust
AVROBIO, Inc. President & CEO, Director Restricted Stock Unit 301K $361K $1.20 Feb 8, 2023 Direct
AVROBIO, Inc. President & CEO, Director Common Stock 188K $227K $1.21 Jan 24, 2023 Direct
AVROBIO, Inc. President & CEO, Director Common Stock 72.6K $87.5K $1.21 Dec 28, 2022 By daughter of reporting person
AVROBIO, Inc. President & CEO, Director Common Stock 72.6K $87.5K $1.21 Dec 28, 2022 By son of reporting person
Talaris Therapeutics, Inc. Director Stock Option (Right to Buy) 20.5K Jun 13, 2023 Direct
AVROBIO, Inc. President & CEO, Director Stock Option (Right to Buy) 0 Jan 24, 2023 Direct

Insider Reports Filed by Geoffrey Mackay

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TALS Talaris Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 14, 2023 Director
AVRO AVROBIO, Inc. Feb 8, 2023 1 $0 4 Feb 10, 2023 President & CEO, Director
AVRO AVROBIO, Inc. Dec 28, 2022 4 $41.9K 4 Jan 26, 2023 President & CEO, Director
AVRO AVROBIO, Inc. Dec 23, 2022 2 $58.7K 4 Dec 28, 2022 President & CEO, Director
AVRO AVROBIO, Inc. Dec 8, 2022 1 $0 4 Dec 9, 2022 President & CEO, Director
TALS Talaris Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
AVRO AVROBIO, Inc. Feb 2, 2022 2 $0 4 Feb 4, 2022 President & CEO, Director
AVRO AVROBIO, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 President & CEO, Director